Top compounds associated with response to CIDEA


Feature Type Standardized
Nominal ANOVA
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.073 0.03
mRNA EX-527 CTRPv2 pan-cancer AAC 0.081 0.03
mRNA Imatinib GDSC1000 pan-cancer AAC -0.11 0.03
mRNA LY-2157299 CTRPv2 pan-cancer AAC 0.15 0.03
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.03
mRNA KU-60019 CTRPv2 pan-cancer AAC -0.072 0.03
mRNA Bortezomib FIMM pan-cancer AAC 0.33 0.04
mRNA foretinib GDSC1000 pan-cancer AAC -0.065 0.04
mRNA BMS-754807 GDSC1000 pan-cancer AAC -0.067 0.04
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.075 0.04
Download CSV